Enhanced Clearance of HIV-1 Broadly Neutralizing Antibody VRC07-523-LS During Viremia: Influences on Trial Design and Analysis. - Smith NM; Ho BM; Bar KJ; Gama L; Dziubla G; Koup RA; Pensiero M; Serebryannyy L; Caskey M; Wilkin TJ; Wood TD; Morse GD; et al. (Clinical and translational science, 2026)